$NTLA

Intellia Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$81.49 β–Ό-1.368%

Last Close

VOLUME

1,359,656

DAY RANGE

82.01 - 89.75

52 WEEK

43.86 - 202.73

Join Discuss about NTLA with like-minded investors

profile
@dros #droscrew
recently

+Initiations 1/7: $ACVA $AER $BILL $CMPO $CSTL $DMTK $DNA $ET $GDRX $IMRX $NRDY $NTLA $OCX $PL $PSTX $RBOT $SSNC $UPWK $VCYT

121 Replies 9 πŸ‘ 6 πŸ”₯

FA
@FabioT #decarolis
recently

poi NTLA ... area 90

80 Replies 10 πŸ‘ 12 πŸ”₯

profile
@Marcosx #ivtrades
recently

$NTLA Nutella ? lol

52 Replies 12 πŸ‘ 9 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

Cathie Wood's ARK Invest Posts Fund Purchases For Monday, Nov. 1, 2021: NTLA, BEAM, PATH, KTOS, VLD, NIU, BLDE, MKFG, ZM, GENI, EXAS, CDNA, ALLO, VERV, ARCT, ADPT, TWLO, HOOD, TOST

46 Replies 9 πŸ‘ 13 πŸ”₯

profile
@dros #droscrew
recently

+Initiations 9/24: $ACHC $AMBP $AVTX $CLBT $CYCN $EHC $FNV $FYBR $HTHT $HUMA $LEV $NTLA $OPEN $OSMT $PAYO $RPD $SMFR $WPM . -Initiations 9/24: $AMED $SPOT $UHS

117 Replies 7 πŸ‘ 14 πŸ”₯

profile
@marketjay #marketassasins
recently

**1) NTLA (INTELLIA)** NTLA has been in a accumulation phase since we identified the possible run up from data trials in mid June, now NTLA has broken above previous $174 resistance level. Like the previous two months as we targeted healthcare due to the imbalance in the market and the outperformance in sector, healthcare is meeting the same previous conditions as this sector is looking to breakout again. With NTLA breaking this level, look for continuation and confirmation of the continued move at the break above $180 for calls for a swing. PT 1: $185, PT2: $190, PT3: $195, allow time by obtaining 09/17/21 if this is toward the beginning of the week, if the end of the week obtain contracts with October's expiration

44 Replies 6 πŸ‘ 14 πŸ”₯

profile
@marketjay #marketassasins
recently

I've had 5 high conviction trades the past 2 months, meaning on my scale of 1 to 5 trade set ups that met 5 stars. SAVA, DXCM, SWBI, NTLA, & MP SAVA netted me a 600% return, DXCM 450%, SWBI 500%, NTLA I didn't trade because of confusion of dates, and MP just didn't work. So I'm 3/5 for those, and these have allowed each account to sit comfortably

85 Replies 14 πŸ‘ 9 πŸ”₯

DO
@Donnieasoff #marketassasins
recently

I have some long term holds I won't be giving up like ntla, UPST, FCX a lot of shit which could get hit but I love been long since such low levels I'm chillin

130 Replies 10 πŸ‘ 11 πŸ”₯

profile
@marketjay #marketassasins
recently

planned for NTLA in June when the data trials were being released and botched the play by being unaware of the date tge weej prior before price jumped from $83 to $160

57 Replies 12 πŸ‘ 15 πŸ”₯

DO
@Donnieasoff #marketassasins
recently

ntla is such a winner I went long stock I February and doubled In March such a winner. lol only regret isn't using leverage

119 Replies 7 πŸ‘ 7 πŸ”₯

profile
@marketjay #marketassasins
recently

I have a extensive watchlist based on data and key dates, previous plays from that list are NTLA, SAVA

88 Replies 15 πŸ‘ 8 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA is creating a W pattern on the daily, watch for the break above $170 for continuation of strength with a PT: $190 with two weeks minimum out

123 Replies 15 πŸ‘ 6 πŸ”₯

profile
@ivtrades-Chris #ivtrades
recently

$NTLA dancing

118 Replies 12 πŸ‘ 14 πŸ”₯

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, August 5, 2021 Futures Up/Down % Last Dow 55.00 0.16% 34,745 S&P 500 9.25 0.22% 4,404 Nasdaq 33.50 0.22% 15,107 U.S. futures are looking up modestly, rising roughly about 0.2% across the board into one of the heaviest days of corporate earnings of the season, as major averages continue to hold not far off record highs. The S&P 500 index has held the pivotal 4,400 level for over a week now, as overall major averages have moved sideways for two or three weeks now, bolstered by rising on better economic data, earnings results, and an accommodative Fed, which has offset rising Delta variant concerns and fears of further global restrictions to contain the rise in cases and tighter government restrictions in China. Oil prices edge higher after sliding sharply the last 3-days on demand concerns. Bitcoin prices are down about 4% holding just above the $38,000 level while Ethereum slips nearly 4% to 2,600 in the crypto sector. Ahead of tomorrow’s nonfarm payrolls report, investors will get two more labor market data points with the Challenger jobs report at 7:30 and the weekly jobless claims. Euro Stoxx 50 rises 0.5% around best levels for the week. Wednesday’s after-hours big-name earnings were disappointing for the most part, which could weigh on sentiment. Major averages ended the session mixed on Wednesday, following conflicting signals on the economy that showed a hot services sector, but a labor market that continues to struggle to find workers. The Institute for Supply Management survey on Wednesday jumped to a record high of 64.1 in July, but the ADP Employment Report showed private payrolls only rose by 330,000 last month, well shy of the 695,000 estimate ahead of tomorrow’s payrolls. The Dow Jones saw the biggest fall, dragged lower by a decline of more than 6% in Amgen in the wake of its quarterly results, accounting for about 103 points to the downside while energy was the weakest sector on the day, suffering its biggest daily percentage drop since July 19. In Asian markets, The Nikkei Index gained 144 points to 27,728, the Shanghai Index dipped -10 points to 3,466 and the Hang Seng Index declined -221 points (0.84%) to settle at 26,204. In Europe, markets are little changed as the German DAX is up a few points at the 15,700 level, while the FTSE 100 is down a couple of points at 7.120. Market Closing Prices Yesterday The S&P 500 Index slipped -20.49 points, or 0.46%, to 4,402.66 The Dow Jones Industrial Average fell -323.73 points, or 0.92%, to 34,792.67 The Nasdaq Composite edged higher 19.24 points, or 0.13%, to 14,780.53 The Russell 2000 Index declined -27.26 points, or 1.23% to 2,196.32 Events Calendar for Today 7:30 AM ET Challenger Job Layoffs for July 8:30 AM ET Weekly Jobless Claims 8:30 AM EST Continuing Claims 10:30 AM ET Weekly EIA Natural Gas Inventory Data Earnings Calendar: Earnings Before the Open: ABMD, ADNT, AES, AHCO, AKBA, AMRS, ARWR, AVEO, BBGI, BCRX, BDX, BERY, BKI, BLDR, BLL, BV, CAH, CARS, CCOI, CHH, CI, CNP, COMM, CRAI, DDOG, DIN, DLX, DUK, ECOM, EPAM, EPC, EVRG, FOUR, GCP, GNL, GOGO, GOLF, GTN, HBI, HBIO, HII, HL, IDCC, INSM, IRM, IRWD, ITI, K, KPTI, LAMR, LAUR, LNG, LXP, MMS, MPLN, MRNA, MUR, MYE, NINE, NS, NTLA, PCTY, PBH, PBPB, PEI, PENN, PH, PNW, PPL, PRTY, PWR, PZZA, RC, RDUS, REGN, ROLL, SEAS, SSYS, TEN, THS, TRGP, UFS, USPH, VG, VIAC, VST, W, WD, WOW, WRK, XEC, XERS, XTNT, XXII, YETI, ZIXI, ZTS Earnings After the Close: AAOI, AEE, AEL, AIG, AINV, ALRM, ALTR, AMBC, APLE, APPN, ARNA, ASTG, AVLR, AXON, BAND, BECN, BGS, BHF, BIGC, BKD, BL, BRBR, BRKS, BYND, CARG, CDXS, CGNX, CHRS, CHUY, CLNE, CNXN, COLD, CSOD, CVNA, CWK, DBX, DHX, DIOD, EB, ECOR, EGLE, ENTA, ENV, ERII, EXEL, EXPE, FEYE, FLDM, FLS, FND, FOXF, FSR, FTSI, G, GDYN, GEOS, GH, GKOS, GPRO, GRPN, GSBD, HASI, HCAT, HCI, HEAR, HTA, IFF, ILMN, IHRT, IOVA, IRTC, ITT, JCOM, KALA, KAMN, LGF.A, LNT, LOCO, LTHM, MAIN, MDRX, MNST, MP, MSI, MTW, MTZ, NET, NKTR, NVAX, NWSA, NYMT, OLED, OUT, PBYI, PK, PODD, POST, PRA, QDEL, RAMP, RDFN, REZI, RMD, RUN, SFM, SGMO, SHAK, SPCE, SQ, SYNA, TDC, TGH, TMDX, TMST, TRUE, TRUP, TTOO, VLDR, VMEO, VOYA, VV, WSC, Y, YELP, ZEUS, ZG, ZNGA Macro Up/Down Last Nymex 0.37 68.52 Brent 0.26 70.64 Gold 0.40 1,811.75 EUR/USD 0.0005 1.1842 JPY/USD 0.03 109.51 10-Year Note -0.004 1.19% Sector News Breakdown Consumer Boot Barn ($BOOT) Q1 EPS $1.35 vs est. $0.88 in revs $306.3M vs est. $288.9M; same-store sales +78.9% vs 1Q20, +52.3% vs 1Q19; opened 3 new stores in the quarter Costco ($COST) reported total comparable sales for July of +13.8%; July U.S. comparable sales excluding fuel, currencies +8.5% L.F. Beauty ($ELF) 1Q EPS $0.15 vs est. $0.15 on sales $97Mm vs est. $79.3Mm; guides FY adj EPS $0.65-0.68 vs est. $0.67, sees FY sales $356-364Mm vs est. $350.5Mm Etsy Inc. ($ETSY) shares tumble -13% on guidance; 2Q EPS $0.68 vs est. $0.63 on revs $528.9Mm vs est. $524.7Mm, qtrly consolidated GMS $3.0B +13%; guides 3Q revs $500-525Mm vs est. $524.7Mm, sees 3Q GMS $2.9-3.0B Frontdoor Inc. ($FTDR) Q2 EPS $0.76 vs est. $0.63 on revs $462M vs est. $466M, sees Q3 revenue $470M-$480M, lowered FY revenue outlook to $1.6B-$1.62B (est. $1.64B) from $1.63B-$1.65B Jack in the Box ($JACK) Q3 EPS $1.79 vs est. $1.49 on revs $269.5M vs est. $258.5M, same-store sales +10.2%, systemwide sales +10.6%, company-operated same-store sales +9.0%, sees FY21 capex $40M-$45M, FY22 capex $65M-$75M Leslie’s ($LESL) Q3 adj EPS $0.64 vs. est. $0.55; Q3 revs $596.54M vs. est. $570.37M; Q3 comparable sales growth of 23.9%; raises FY21 adjusted EPS view 80c-85c from 75c-80c (est. 77c) and boosts FY21 revs to $1.31B-$1.33B from $1.28B-$1.3B (est. $1.3B); Adjusted EBITDA of $179.3 million compared to $119.8 million in the prior year quarter, an increase of 49.7% MGM Resorts ($MGM) 2Q adj EPS ($0.13) vs est. ($0.30) on net revs $2.3B vs est. $2.28B, MGM China net revs $311Mm, LV Strip net revs $1.0B, regional net revs $856Mm Rent-A-Center ($RCII) 2Q adj EPS $1.63 vs est. $1.35 on revs $1.2B vs est. $1.14B, qtrly comps +16.6% led by e-comm; guides FY revs $4.55-4.67B vs est. $4.56B, sees Rent-A-Center segment revs $2.02-2.06B, sees FY adj EPS $5.90-6.40 vs est. $5.66; announces $250Mm repurchase auth Uber ($UBER) Q2 EPS $0.58 on revs $3.93B vs. est. $3.74B; Q2 gross bookings grew 114% yoy to $21.9 billion, or 104% on a constant currency basis, with Mobility Gross Bookings of $8.6 billion and Delivery Gross Bookings of $12.9 billion; Q2 Adj EBITDA Loss $509M vs. est. loss $324.5M; sees Q3 Adj EBITDA loss below $100M vs. est. loss $95.4M Wynn Resorts (WYNN) 2Q adj EPS ($1.12) vs est. ($1.61) on revs $990.1Mm vs est. $932.5Mm, Wynn Macau revs $184Mm, LV ops revs $355.1Mm ADT Inc. ($ADT) adj EPS ($0.07) vs est. $0.25 on revs $1.304B vs est. $1.28B; Gross recurring monthly revenue (RMR) additions grew 28%; end of period RMR of $352 million increased by 4%; solid customer retention with attrition at 13.3% Driven Brands ($DRVN) 12M share Secondary priced at $29.50 European Wax Center ($EWCZ)6M share IPO priced at $17.00 Weber ($WEBR) 18M (which was cut down from 46.8M) share IPO priced at $14.00 Energy APA Inc. ($APA) Q2 adj EPS $0.70 vs. est. $0.57’ Q2 revs $1.75B vs. est. $1.46B; qtrly adjusted production, which excludes Egypt noncontrolling interest and tax barrels, was 342,000 boe per day; at current strip prices, we expect to generate approximately $1.7B of free cash flow this year Earthstone Energy ($ESTE) files for offering of up to 6.2 mln shares of class a common stock by selling stockholders Marathon Oil ($MRO) Q2 EPS $0.22 vs. est. $0.15; Q2 revs $1.14B vs. est. $1.09B; Q2 oil-equivalent production of 348,000 net boed; raising 2021 full year oil-equivalent production guidance by 5,000 net boed; Q2 oil production of 170,000 net bopd; raised quarterly base dividend by 25% to 5c; raising the midpoint of its 2021 full year U.S. oil-equivalent production guidance by 5,000 net boed Warrior Met Coal ($HCC) 2Q adj EPS $0.25 vs est. ($0.18) on revs $227.4Mm vs est. $128.3Mm; not providing FY guide at this time Whiting Petroleum ($WLL) Q2 adj EPS $3.01 vs. est. $1.97; Q2 revs $352M vs. est. $244.27M; said generated net cash provided by operating activities of $183M and $111M in adjusted free cash flow during the quarter and over $200 million through six months; raises FY21 production view to 88-92 MBOE per day from 82-88 Financials Allstate Corp. ($ALL) Q2 adj EPS $3.79 vs. est. $3.04; Q2 revs $12.65B vs. est. $10.51B; announces new $5B repurchase program; 2Q Book Value Per Shr $86.33; Q2 Catastrophe Loss $952M; Q2 Property-Liability Premiums Earned $10.01B; 2Q Property-Liability Premiums Written $10.32B;2Q Property-Liability Combined Ratio 95.7 Fleetcor ($FLT) Q2 EPS $2.30 vs est. $2.94, adj EPS $3.15, on revs $667.4M vs est. $637.3M; its board increased its share repurchase authorization by$1B; sees Q3 adj EPS $3.35-$3.55 vs est. $3.36, and raised outlook for FY adj EPS to $12.80-$13 (est. $12.61) from $12.32-$12.88 and FY revs to $2.74B-$2.79B (est. $2.68B) from $2.6B-$2.7B Lemonade ($LMND) Q2 EPS loss (-$0.90) vs. est. loss (-$0.89); Q2 revs $28.2M vs. est. $26.8M; customer count increased by 48% to 1,206,172 yoy; premium per customer, defined as in force premium divided by customers, was $246 at the end of the second quarter, up 29% yoy; raises FY21 revenue view to $123M-$125M from $117M-$120M (est. $118.94M); narrows FY21 adjusted EBITDA view to ($173M)-($169M) from ($173M)-($163M) Lincoln National ($LNC) Q2 adj operating EPS $3.17 vs. est. $2.35; Q2 revs $4.85B vs. est. $4.72B; Reports book value per share, including AOCI, of $115.00, up 7%; BVPS, excluding AOCI, of $75.45, up 9% MetLife ($MET) announces new $3B share repurchase authorization; Q2 adj EPS $2.37 vs. est. $1.57; Q2 revs $18.52M vs. est. $15.77B; qtrly premiums, fees & other revenues $11.22 bln vs $10.49 bln; qtrly net investment income $5.28 bln vs $4.09 bln; book value of $75.86 per share at qtr-end, down 4% from $78.65 per share at June 30, 2020 RE/MAX Holdings ($RMAX) 2Q adj EPS $0.63 vs est. $1.31 on revs $77.2Mm vs est. $76.4Mm; guides 3Q revs $86.5-91.5Mm vs est. $79.1Mm; sees FY revs $321-336Mm vs est. $308.7Mm Western Union (WU) Q2 adj EPS $0.48 vs. est. $0.47; Q2 revs $1.3B vs. est. $1.26B; reaffirms FY21 adj EPS view $2.00-$2.10 vs. est. $2.06; reaffirms FY21 revenue growth view mid-to-high single digits; Consumer-to-Consumer (C2C) transactions increased 15% in the quarter, while revenues increased 15% on a reported basis, or 12% constant currency. Robinhood ($HOOD) filed with the SEC a prospectus related to the offer and sale from time to time of up to 97,876,033 shares of Class A common stock of Robinhood Markets, Inc. by certain selling stockholders

70 Replies 12 πŸ‘ 7 πŸ”₯

profile
@marketjay #marketassasins
recently

to be real deep down im still whining to myself how did i botch NTLA

62 Replies 13 πŸ‘ 13 πŸ”₯

profile
@dros #droscrew
recently

$NTLA ceo on CNBCΒ 

138 Replies 8 πŸ‘ 12 πŸ”₯

profile
@marketjay #marketassasins
recently

damn dropped the ball on those NTLA 90 calls, completely missed timed it

112 Replies 14 πŸ‘ 10 πŸ”₯

profile
@Navneet #droscrew
recently

$ntla 155 calls flow yesterday came 2.50

121 Replies 14 πŸ‘ 11 πŸ”₯

profile
@marketjay #marketassasins
recently

SWBI 25 call signaled .47 ran as high as 10.70 today with another 2 week's to go, ASTS 12.50 call alerted at 1.82 ran as high as 5.00 today, QSI 10 call alerted at .95 ran as high as 3.80, all of these don't expire until 07/16. That is only this months top plays, without including the NTLA blunder, we still got the 2nd half of this year guys so EVERYBODY KEEP GRINDING

43 Replies 15 πŸ‘ 14 πŸ”₯

profile
@marketjay #marketassasins
recently

everyone here and in the Capatalist Academy should've caught NTLA as it was on our watchlist and we had a discussion call about it and i lost track of the date

134 Replies 14 πŸ‘ 7 πŸ”₯

profile
@marketjay #marketassasins
recently

Previous moves from off the extended watchlist that made it to the weekly watchlist ETSY 06/21 went $169 to $202, NTLA 06/13 on the watchlist and alerted that phase 1 data was to be released, went from $85 to currently $151, NOW 06/18 went from $510 to now $558. Some plays on the weekly watchlist come from my extended watchlist unfortunately I'm human I will miss my own plays sometimes as I waited for NTLA and missed time it by a week. So use the watchlist as a screener @everyone

90 Replies 8 πŸ‘ 12 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA shares trading higher today due to positive trial data this is positive and provides future clarity on CRSP technology

124 Replies 7 πŸ‘ 11 πŸ”₯

profile
@dros #droscrew
recently

yeah in sympathy with ntlaΒ 

126 Replies 13 πŸ‘ 7 πŸ”₯

profile
@dros #droscrew
recently

$NTLA lit on drug trial resultsΒ 

48 Replies 10 πŸ‘ 13 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$NTLA to $110/$163

144 Replies 12 πŸ‘ 10 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA with a strong recovery

139 Replies 6 πŸ‘ 8 πŸ”₯

profile
@marketjay #marketassasins
recently

Closed NTLA for a loss 1.35, small position but never wan to wait to long to close these

136 Replies 7 πŸ‘ 12 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA tanked

61 Replies 13 πŸ‘ 8 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA slightly green but sideways without the conviction and follow through

41 Replies 12 πŸ‘ 12 πŸ”₯

profile
@marketjay #marketassasins
recently

DXCM NTLA favorable momentum

52 Replies 9 πŸ‘ 13 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA creeping

119 Replies 15 πŸ‘ 13 πŸ”₯

profile
@marketjay #marketassasins
recently

Currently NOW is a voided trade off the watchlist as it played out the way we wanted yesterday, MSTR already achived, ATVI and REGN have not met criteria yet, HON, NTLA, and DXCM all active, ADBE moving strongly but I will be waiting for earnings

134 Replies 11 πŸ‘ 7 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA pre market got as high as $89.32, still holding our $90 call

40 Replies 9 πŸ‘ 9 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA and HON light swings

95 Replies 11 πŸ‘ 9 πŸ”₯

profile
@marketjay #marketassasins
recently

And swing trade DXCM, NTLA, and HON

49 Replies 9 πŸ‘ 13 πŸ”₯

profile
@marketjay #marketassasins
recently

Volume is stepping into NTLA, want to see higher volume as this is gaining momentum

85 Replies 6 πŸ‘ 10 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA 06/18 90 calls 2.40 (light position) liquidity and volume are jusyt now stepping in as this is breaking out. Plan was for july contracts but volume has still not been received on that chain

128 Replies 15 πŸ‘ 12 πŸ”₯

profile
@marketjay #marketassasins
recently

NTLA confirmed but no liquidity is no good

61 Replies 12 πŸ‘ 9 πŸ”₯

profile
@marketjay #marketassasins
recently

watching NTLA A+ set up on the play but there is no volume on the 90 calls for June or July which sucks may just buy shares because they are a great company for anyone interested in genomics they're my number 2 genomic company after CRSP

148 Replies 12 πŸ‘ 6 πŸ”₯

profile
@marketjay #marketassasins
recently

**6) NTLA (Intellia Therapeutics)** Intellia Therapeutics has been in a large range since 01/15/21, now NTLA is nearing a key level where we could see high volatility. This is due to their announcement to release the data for their phase 1 clinical data on 06/26/21 for their treatment of Transthyretin. Also HC Wainwright and CO updated NTLA to a buy rating with $111 price target. This is a A + set up with a catalyst. High potential swing, will be eyeing $90 calls for July, PT N/A

80 Replies 14 πŸ‘ 9 πŸ”₯

Key Metrics

Market Cap

6.07 B

Beta

2.41

Avg. Volume

897.68 K

Shares Outstanding

73.49 M

Yield

0%

Public Float

0

Next Earnings Date

2022-02-24

Next Dividend Date

Company Information

Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creating enhanced engineered cells that can treat oncological and immunological diseases. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create new classes of therapeutic products.

CEO: John Leonard

Website:

HQ: 40 Erie St Ste 130 Cambridge, 02139-4254 Massachusetts

Related News